NCT05161546TERMINATEDanonymous

Study of Bipolar Disorders and Retinal Electrophysiological Markers

Sponsor

Source record

Centre Psychothérapique de Nancy

Phase

Source record

Modality

AI-normalized

medical device

Target

AI-normalized

EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT)

Indication / condition

AI-normalized

Bipolar Disorder

Intervention

Source record

EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT)

Source & freshness

Source record

NCT ID

NCT05161546

Original source

ClinicalTrials.gov

Source last updated

Aug 22, 2024

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT05161546

Title

Study of Bipolar Disorders and Retinal Electrophysiological Markers

Sponsor

Centre Psychothérapique de Nancy

Status

TERMINATED

Phase

Condition raw

Bipolar Disorder

Condition normalized

Bipolar Disorder

Modality raw

medical device

Modality normalized

medical device

Target raw

EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT)

Target normalized

EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT)

Interventions

EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT)

Public preview

Source record

Study of Bipolar Disorders and Retinal Electrophysiological Markers is a NA clinical asset sponsored by Centre Psychothérapique de Nancy in Bipolar Disorder. SEO and diligence focus: EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Study of Bipolar Disorders and Retinal Electrophysiological Markers

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT05161546

Status

TERMINATED

Phase

Sponsor

Centre Psychothérapique de Nancy

Executive brief

Investment-Ready Snapshot

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedAug 22, 2024

Internal syncJun 09, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT05161546

Indication

Bipolar Disorder

Modality

medical device

Target

EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT)

Intervention

EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT)

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.